Here is a bit of speculation, Maybe RVX may have some serious interest for a CVR deal from Gilead an Israeli large pharma beating Pfizer/ AZ or BM to the deal before they get seriously interested
here a post from Aureus from IV with a similar possible opinion
Gilead .. Sure
Gilead has a BET inhibitor in trials for mcrPC
HIV another possible area of mutual interest
They know that Ze and RVX do also
RVX / Ze connection obvious to them
Gilead modus operandi in Hep C was to
acquire the compound for something like 10 B ? Not sure from memory ?
and then watched it add 10X purchase price to market cap for them
So its not a stretch to see Gilead buy or partner with one or both
Gilead has both tons of cash and their own shares they
could offer
Certainly a candidate do watch
